SEC Form 4 · accession 0000899243-18-004643
Deciphera Pharmaceuticals, Inc. · DCPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Douglas Taylor
Officer — See Remarks · Director
Period of report
Feb 16, 2018
Accepted (ET)
Feb 20, 2018 · 6:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001654151
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $29.71 | Feb 16, 2018 | A | 225,000 | A | — | Feb 16, 2028 | Common Stock | 225,000 | 225,000 | D |
Explanation of responses
- F1This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option vests in 48 equal monthly installments following the vesting commencement date of January 1, 2018, subject to continued service through such dates.
Remarks
President and Chief Executive Officer